Clover Health Investments, Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Andrew Toy
- Full Time Employees
- 724
- Sector
- Finance
- Industry
- Life/Health insurance
- Address
- 1209 Orange Street Wilmington DE United States 19801
- IPO Date
- Jun 12, 2020
- CIK
- 0001801170
- Website
- cloverhealth.com
- Similar Companies
- Business
- Clover Health Investments, Corp. is a healthcare technology company primarily focused on providing Medicare Advantage insurance plans combined with a proprietary software platform designed to improve clinical outcomes and reduce healthcare costs. The company offers a comprehensive suite of insurance products including Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans targeting Medicare-eligible seniors, with a differentiated focus on wide-network, high-choice PPO plans. Clover Health’s flagship software, Clover Assistant, integrates patient data from over 100 sources using artificial intelligence, natural language processing, and machine learning to empower physicians in proactive chronic disease management and enhance quality of care. The company also extends its technology through its subsidiary Counterpart Health, which licenses its AI-driven platform to third-party healthcare providers. Founded in 2014 and headquartered in Wilmington, Delaware, Clover Health operates Medicare Advantage plans in five states, serving over 100,000 members with coverage spanning 203 counties, including plans with $0 to low monthly premiums and additional benefits such as dental, vision, hearing, and over-the-counter drug coverage. The company’s insurance segment generates revenues through Medicare contracts, while its technology platform aims to improve physician efficiency and patient health outcomes. Clover Health stands out with its AI-powered HEDIS flywheel, which has driven it to become the top-performing PPO plan by clinical quality measures. Recent major developments include the launch of the 2026 Medicare Advantage portfolio with a stable or improved plan lineup accessible to 5.2 million Medicare beneficiaries, emphasizing broader PPO coverage and AI-supported care through Clover Assistant. The company reported significant growth in 2025, with Medicare Advantage membership up 35% year-over-year, total revenues increasing 50%, and a move toward profitability with adjusted EBITDA improving notably. Clover Health also raised its full-year 2025 guidance, highlighting expectations for continued membership growth, expanded adjusted EBITDA profitability through 2027, and a favorable regulatory environment in Medicare Advantage. Additionally, the company made its AI platform available to third-party partners on October 14, 2025, advancing its strategic shift toward scaling technology beyond insurance offerings. Clover Health went public in early 2021 through a merger with Social Capital Hedosophia Holdings Corp. III and continues to focus on healthcare equity for seniors, extending access to affordable, comprehensive Medicare plans. It combines health insurance with advanced data-driven technology solutions to enhance care quality and reduce medical costs, positioning itself as both a health insurer and a healthcare technology innovator within the Medicare Advantage market. The company is committed to expanding its technology-enabled healthcare services and participating in the evolving value-based care landscape. This profile reflects Clover Health Investments Corp.'s current operations, product offerings, and strategic developments as of late 2025.
Company News
Clover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 14,673 Shares of Company Stock
Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 62,176 Shares of Stock
Clover Health Investments (NASDAQ:CLOV) CEO Conrad Wai Sells 23,627 Shares of Stock
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
At 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
Clover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D.
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D.
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
Tidal Investments LLC Takes $2.16 Million Position in Clover Health Investments, Corp. $CLOV
Clover Health Investments (NASDAQ:CLOV) Stock Price Down 6.5% Following Insider Selling
Clover Health to Participate in Upcoming Investor Conferences
Clover Health Is A 'Buy' Because Of Its AI
Clover Health Investments: Real Turnaround, But Already Priced In
Clover Health Is Proving Its Profit Model
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
Clover Health Investments Q2 Earnings Call Highlights